Active Development

AI / Psychometrics / NeuroTech / GameDev

🧠iWendy 2.0

AI Personality Intelligence Platform combining scientifically-validated psychometrics (IRT), EEG neurofeedback, LLMs, and GameDev into a unified personality engine. The only platform in CIS merging all four layers.

The Problem

46% of new hires fail within 18 months due to personality mismatch. Existing psychometric tools are slow (30-60 min), easy to cheat, and disconnected from real-world applications in gaming and neurotech. There is no integrated AI personality intelligence solution in the CIS market.

Four Product Lines

iWendy for Business
B2B SaaS: AI candidate screening (5 min vs 60), team DNA mapping, culture fit, leadership assessment
B2B SaaS
iWendy App
B2C mobile: Personality Passport, Career Navigator (2,127 professions), compatibility engine, AI growth coach
Freemium
GameDev SDK
NPC Persona Engine, player profiling from gameplay behavior, adaptive narratives, team matchmaking
License + Royalty
NeuroWell
EEG neurofeedback + psychometrics for objective personality validation, stress mapping, AI-personalized protocols
B2B + B2C

Technology

Built on psycho-core engine — IRT-validated, ready to deploy:

  • 75 IRT-calibrated questions with 0.9+ reliability in under 5 minutes
  • 16 MBTI profiles, 2,127 career mappings, compatibility matrices
  • LLM layer (Claude/Llama) for natural language personality insights
  • EEG signal processing for objective neuro-validation (patented methodology)

Market & Traction

$30B+
TAM by 2033
4
Product Lines
2,127
Career Mappings
$300K
Seed Round
Raising Seed

HealthTech / Clinical AI / Agentic Architecture

🧬Regain

Clinical AI platform with autonomous agents for differential diagnosis and treatment optimization. Applying for ARPA-H ADVOCATE program ($20M grants). Hermes Protocol released as open-source standard. regain.ai →

The Problem

Clinical decision-making is fragmented, error-prone, and unscalable. Hospital IT systems (LIS, CRM, BI) don't talk to each other. AI in healthcare lacks regulatory approval and deterministic safety. The FDA pathway is so complex that only tech giants attempt it — creating an opportunity for focused startups.

Technology: Agentic Clinical Architecture

A multi-agent system that replicates a clinical board of experts — no proprietary neural networks, but a unique orchestration layer:

DEUTSCH (TA1) — Clinical Agent
Three-agent reasoning via ArgMed debate: Generator → Verifier → Reasoner. 68 vignettes, 6 scoring layers, 8 CVD conditions. 4,000+ patients in production.
POPPER (TA2) — Safety Supervisor
Deterministic 7-gate pipeline. 47ms median response. Zero LLMs in safety-critical path. Can approve, hard-stop, or escalate to human physician.
Hermes Protocol (Open Source)
Apache 2.0 communication standard enabling any TA1 to work with any TA2. Structurally enforces epistemic metadata. Released February 5, 2026. Goal: become the industry standard for clinical AI safety.

Products

Mobile App
"The Everything Health App" — wearables, lab data, telemedicine, built-in clinic
B2C
Medical OS (MIS)
Super-integrated clinical system replacing fragmented LIS+CRM+BI stacks
B2B Enterprise
Agent API
Modular clinical agents (TA1+TA2) pluggable into any system via API
Platform

Regulatory & Partnerships

  • ARPA-H ADVOCATE: Applied for $20M in two grants (clinical + supervisor agents). Deadline April 1, 2026
  • FDA Tempo: Pre-certification program application in progress
  • UI Health (Chicago): LOI signed, Dr. Mladen Vidovich (FACC, FSCAI) as PI, Epic EHR, IRB-ready
  • FDA Panel Advisor: Cardiologist and FDA panel member on advisory board

Traction

4,000+
Patients Served
47ms
Safety Response
$20M
ARPA-H Applied
UI Health
Clinical Partner
Raising Seed

DeepTech / Industrial / Materials Science

🔩ALUMINICO

Revolutionary Hot Aluminizing Technology for Structural Steel. First horizontal aluminizing process using MHD locks — 64% cheaper than zinc galvanizing.

The Problem

Corrosion costs the global economy $2.2 trillion annually. Aluminum coating outperforms zinc, but hot aluminizing only works for flat sheets — not shaped structural products like pipes and beams.

Our Solution

ALUMINICO invented MHD (magnetohydrodynamic) locks enabling horizontal aluminizing:

  • 64% cost reduction: $53/ton vs $147.5/ton for zinc galvanizing
  • 9x smaller bath size: 2.5 m³ vs 24.3 m³
  • 62% less metal consumption: 23.3 kg/ton vs 61.7 kg/ton
  • Superior corrosion protection with aluminum coating

Business Model

Pilot Production
$200+/ton margin, 5,000 tons/year capacity in Uzbekistan
Revenue
Technology Licensing
~4% royalty, targeting $2.4M/year from Year 4
Scale

Traction

$600K
World Bank Grant
2 PCT
Patents Filed
64%
Cost Savings
2025
Pilot Launch
Raising Series A

GameDev / Creative Industries / Entertainment

🎮Lipsar Studio

Turn-based tactics gaming studio with 100+ shipped titles and $10M+ lifetime revenue. Licensed to develop games in the World of Darkness universe (Paradox Interactive).

The Problem

The turn-based tactics genre is underserved by major publishers despite a loyal and growing audience. Most studios lack the proprietary technology and IP access needed to create premium experiences at scale.

Our Solution

Lipsar has built a proprietary game engine optimized for turn-based tactics, enabling rapid development and premium quality:

  • Proprietary engine with 10+ years of iterative improvement
  • World of Darkness license — Night Hunters flagship title
  • Pipeline of AAA IP partnerships (major tabletop and gaming franchises)
  • Cross-platform: PC (Steam), Mobile (iOS/Android), Console

Business Model

Premium Games
$19.99–$29.99 Steam titles with DLC expansion packs
B2C
Mobile F2P
Free-to-play with in-app purchases and season passes
B2C
IP Licensing
Revenue share from licensed franchise games
B2B

Traction

100+
Games Shipped
$10M+
Lifetime Revenue
50M+
Downloads
29
Team Members
Due Diligence

BioTech / HealthTech / Genomics

🧬AGC Genomics

Kazakhstan's first local next-generation sequencing (NGS) genetic testing platform. Bringing affordable, accessible genomic diagnostics to a 20M+ population with less than 1% market penetration.

The Problem

Kazakhstan lacks local NGS genetic testing infrastructure. All samples are sent abroad — increasing costs ($600–$2,500 per test), turnaround time (4–6 weeks), and creating data sovereignty risks. Less than 1% of the population has access to genetic diagnostics.

Our Solution

AGC Genomics establishes a full-cycle local NGS laboratory with international technology partnerships:

  • 4 product lines: Prenatal screening (NIPT), whole exome sequencing (WES), colorectal cancer screening (COLOTECT), preimplantation genetic testing (PGT-A)
  • 30–50% cost reduction vs. sending samples abroad
  • Turnaround time: 5–10 business days (vs. 4–6 weeks)
  • Local data processing compliant with Kazakhstan regulations

Market Opportunity

NIPT
400K pregnancies/year, non-invasive prenatal screening
$50M+ TAM
Oncology
Early detection colorectal cancer screening
COLOTECT
Rare Diseases
Whole exome sequencing for genetic disorders
WES

Traction

20M+
Population
<1%
Penetration
4
Product Lines
JV
Partnership

Our Pipeline

We actively evaluate startups in Creative Industries and DeepTech

🎮

GameDev

Mobile games, AR/VR experiences, gaming platforms

🌱

AgriTech

Precision agriculture, supply chain, sustainability

💚

GreenTech

Clean energy, waste management, carbon reduction

Join Our Portfolio

Are you building something innovative in Creative Industries or DeepTech? We'd love to hear about your venture.

Apply as Founder